Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1995-2-16
|
pubmed:abstractText |
O-acetyl GD3 ganglioside is a cell surface molecule of some neural, neural crest and renal cells. Here we show, by using mAbs specific for O-acetyl GD3 (clone 27A) and flow-cytometric, biochemical or immunological techniques, that it is also expressed at high intensity level on the surface of 49.6% (median) of the CD3+ cells (T lymphocytes), at medium level in 16.2% of the CD16+ (natural killer) cells, at very low level in 51.9% of CD14+ cells (monocytes) and in 6.9% of CD20+ cells (B lymphocytes), but not in other human blood cells. Of the CD4+ or CD8+ cells, 52.6 or 36.5% respectively were 27A+. Furthermore, 81.6% of the CD45RO+ lymphocytes carried the O-acetyl GD3 ganglioside. It was not detected in the thymus, although its immediate precursor, the GD3 ganglioside, was present in the medullary thymocytes, suggesting that O-acetyltransferases are regulated by maturation events taking place in the periphery. The anti-O-acetyl GD3 antibodies induced a strong mitogenic response in cultured peripheral blood mononuclear cells, but not in purified T cells. However, in combination with phorbol myristate acetate the antibodies induced proliferation also in purified T cells, suggesting that protein kinase C priming is needed for this effect. This and the restricted expression of O-acetyl GD3 suggest a functional role for this ganglioside in T cell subpopulations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Gangliosides,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/ganglioside, GD3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0953-8178
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1409-16
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7819150-Antibodies, Monoclonal,
pubmed-meshheading:7819150-Antigens, CD,
pubmed-meshheading:7819150-Cell Line,
pubmed-meshheading:7819150-Flow Cytometry,
pubmed-meshheading:7819150-Fluorescent Antibody Technique,
pubmed-meshheading:7819150-Gangliosides,
pubmed-meshheading:7819150-Humans,
pubmed-meshheading:7819150-Killer Cells, Natural,
pubmed-meshheading:7819150-Lymphocyte Activation,
pubmed-meshheading:7819150-Monocytes,
pubmed-meshheading:7819150-Protein Kinase C,
pubmed-meshheading:7819150-T-Lymphocyte Subsets,
pubmed-meshheading:7819150-Thymus Gland,
pubmed-meshheading:7819150-Tumor Cells, Cultured
|
pubmed:year |
1994
|
pubmed:articleTitle |
O-acetyl GD3 ganglioside in human peripheral blood T lymphocytes.
|
pubmed:affiliation |
Department of Bacteriology and Immunology, University of Helsinki, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|